My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 224

    1.

    Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy.

    Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR.

    Ann Intern Med. 2003 Feb 18;138(4):338-46. Review.PMID: 12585833 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Enzyme replacement therapy in Fabry disease: clinical implications.

    Breunig F, Knoll A, Wanner C.

    Curr Opin Nephrol Hypertens. 2003 Sep;12(5):491-5. Review.PMID: 12920395 [PubMed - indexed for MEDLINE]Related articles

    3.

    Fabry disease: focus on cardiac manifestations and molecular mechanisms.

    Perrot A, Osterziel KJ, Beck M, Dietz R, Kampmann C.

    Herz. 2002 Nov;27(7):699-702.PMID: 12439642 [PubMed - indexed for MEDLINE]Related articles

    4.

    Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.

    Ortiz A, Oliveira JP, Wanner C, Brenner BM, Waldek S, Warnock DG.

    Nat Clin Pract Nephrol. 2008 Jun;4(6):327-36. Epub 2008 Apr 22.PMID: 18431378 [PubMed - indexed for MEDLINE]Related articles

    5.

    Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.

    Mignani R, Cagnoli L.

    J Nephrol. 2004 May-Jun;17(3):354-63. Review.PMID: 15365954 [PubMed - indexed for MEDLINE]Related articles

    6.

    Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy.

    Desnick RJ, Banikazemi M.

    Nephrol Ther. 2006 Jan;2 Suppl 2:S172-85.PMID: 17373219 [PubMed - indexed for MEDLINE]Related articles

    7.

    Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.

    Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M.

    Eur J Clin Invest. 2004 Mar;34(3):236-42.PMID: 15025684 [PubMed - indexed for MEDLINE]Related articles

    8.

    Early therapeutic intervention in females with Fabry disease?

    Hughes DA.

    Acta Paediatr Suppl. 2008 Apr;97(457):41-7. Review.PMID: 18339187 [PubMed - indexed for MEDLINE]Related articles

    9.

    Anderson-Fabry disease in Austria.

    Lorenz M, Hauser AC, Püspök-Schwarz M, Kotanko P, Arias I, Zodl H, Kramar R, Paschke E, Voigtländer T, Sunder-Plassmann G.

    Wien Klin Wochenschr. 2003 Apr 30;115(7-8):235-40.PMID: 12778775 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Fabry disease. Clinical and genetic aspects. Therapeutic perspectives]

    Germain DP.

    Rev Med Interne. 2000 Dec;21(12):1086-103. Review. French. PMID: 11191676 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up]

    Lidove O, Bekri S, Goizet C, Khau Van Kien A, Aractingi S, Knebelmann B, Choukroun G, Tsimaratos M, Redonnet-Vernhet I, Lacombe D, Jaussaud R.

    Presse Med. 2007 Jul-Aug;36(7-8):1084-97. Epub 2007 Feb 2. Review. French. PMID: 17276649 [PubMed - indexed for MEDLINE]Related articles

    12.

    Fabry disease in the era of enzyme replacement therapy: a renal perspective.

    Cho ME, Kopp JB.

    Pediatr Nephrol. 2004 Jun;19(6):583-93. Epub 2004 Apr 3. Review.PMID: 15064943 [PubMed - indexed for MEDLINE]Related articles

    13.

    Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement.

    Pisani A, Spinelli L, Sabbatini M, Andreucci MV, Procaccini D, Abbaterusso C, Pasquali S, Savoldi S, Comotti C, Cianciaruso B.

    Am J Kidney Dis. 2005 Jul;46(1):120-7.PMID: 15983965 [PubMed - indexed for MEDLINE]Related articles

    14.

    Fabry disease: recent advances in enzyme replacement therapy.

    Germain DP.

    Expert Opin Investig Drugs. 2002 Oct;11(10):1467-76. Review.PMID: 12387706 [PubMed - indexed for MEDLINE]Related articles

    15.

    Fabry disease during childhood: clinical manifestations and treatment with agalsidase alfa.

    Ramaswami U.

    Acta Paediatr Suppl. 2008 Apr;97(457):38-40. Review.PMID: 18339186 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Fabry's disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects]

    Germain DP.

    J Soc Biol. 2002;196(2):161-73. Review. French. PMID: 12360745 [PubMed - indexed for MEDLINE]Related articles

    17.

    Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy.

    Banikazemi M, Ullman T, Desnick RJ.

    Mol Genet Metab. 2005 Aug;85(4):255-9.PMID: 15939645 [PubMed - indexed for MEDLINE]Related articles

    18.

    Enzyme replacement therapy of Fabry disease.

    Clarke JT, Iwanochko RM.

    Mol Neurobiol. 2005 Aug;32(1):43-50. Review.PMID: 16077182 [PubMed - indexed for MEDLINE]Related articles

    19.

    Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy--a retrospective analysis from the Fabry Outcome Survey.

    Hoffmann B, Beck M, Sunder-Plassmann G, Borsini W, Ricci R, Mehta A; FOS European Investigators.

    Clin J Pain. 2007 Jul-Aug;23(6):535-42.PMID: 17575495 [PubMed - indexed for MEDLINE]Related articles

    20.

    Fabry disease. A case report.

    Kotnik J, Kotnik F, Desnick RJ.

    Acta Dermatovenerol Alp Panonica Adriat. 2005 Mar;14(1):15-9.PMID: 15818441 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity